Glenn Geidel

18PUBLICATIONS
42CO-AUTHORS
Molecular targetsEpidemiological modellingHaematological tumoursTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 12, 2026
Unraveling the Plasma Extracellular Vesicles Proteome: Predictors of Resistance in Immunotherapy of Advanced Melanoma.

|Jun 11, 2026
Current state of medical care for patients with mycosis fungoides and Sézary syndrome at a German university hospital - a cross-sectional study.

|May 16, 2026
Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany.

|Apr 27, 2026
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition.

|Mar 05, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Elizabeth M Gaughan, Miso Kim, Ignacio Mendez

|Jan 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis.

Glenn Geidel, Sabrina Bänsch, Laura Adam

Pageof 3

Frequent Collaborators

12 joint publications

Christoffer Gebhardt

10 joint publications

Julian Kött

6 joint publications

Stefan W Schneider

5 joint publications

Daniel J Smit